Biocon (BIOCON)
FAST GROWERFairStock Score: 38/100 — MIXED
Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹357.8 |
| Market Cap | ₹63,182.98 Cr |
| P/E Ratio | 76.95 |
| ROCE | 6.25% |
| ROE | 2.79% |
| Dividend Yield | 0.13% |
| Profit Growth | -24.88% |
| Debt/Equity | 0.62 |
| Sales Growth | 13.99% |
| Free Cash Flow | ₹3,85,800 Cr |
| Promoter Holding | 44.91% |
| 52-Week Range | ₹331 — ₹440.3 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹133.53 |
Biocon trades with a P/E ratio of 76.95, ROCE of 6.25%, ROE of 2.79%, profit growth of -24.88%, debt-to-equity of 0.62. The FairStock Score of 38/100 flags concerns across multiple fundamental dimensions that investors should examine carefully.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer